Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can counting carbs help people with type 1 diabetes tame blood sugar?

NCT ID NCT07834801

NEW Disease control Sponsor: Acibadem University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 22, 2026 · Last updated Sep 22, 2026

Summary

Researchers are testing whether a structured carbohydrate-counting education program helps adults with type 1 diabetes improve their blood sugar control. Thirty adults aged 19 to 65 who use continuous glucose monitors and multiple daily insulin injections or an insulin pump receive personalized training from a diabetes dietitian over 12 weeks. The study measures changes in time spent in the target blood sugar range, HbA1c, insulin needs, weight, and dietary intake, and compares individually determined insulin-to-carbohydrate ratios with formula-based estimates.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured carbohydrate-counting education delivered by a diabetes dietitian
What this could lead to
If it helps, this could give adults with type 1 diabetes a practical, low-cost way to improve daily blood sugar control and fine-tune insulin dosing.
What could go wrong
The study is small, with 30 participants, and lasts only 12 weeks, so any improvements may not last or apply to everyone. Carb counting takes time and effort, and results depend on how closely people follow the plan.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Feb 2022

Finished

May 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age 19-65 years Diagnosis of type 1 diabetes for at least 1 year Treatment with multiple daily insulin injections or continuous subcutaneous insulin infusion HbA1c ≤10% Body mass index (BMI) 19-30 kg/m² C-peptide \<0.8 ng/mL Use of a continuous glucose monitoring system No communication difficulties No previous knowledge of carbohydrate counting and willingness to receive carbohydrate-counting education - Exclusion Criteria: Gastroparesis Diabetic nephropathy Pregnancy Celiac disease Eating disorder Food allergy Gastrointestinal disease or malabsorption Inability to adhere to the study protocol Withdrawal of consent Discontinuation of continuous glucose monitoring during follow-up \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 1 diabetes mellitus are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 1 diabetes mellitus

Contacts and locations

Locations

  • Turkish Diabetes Foundation Küçükyalı Internal Medicine Center

    Istanbul, Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.